Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
antibiotics
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
2
×
indiana top stories
life sciences
merck
2
×
multiple myeloma
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
arvinas
astrazeneca
What
approval
bio
biogen’s
biopharmaceutical
biotechs
chose
close
companies
company
convo
device
drug
earlier
failures
firms
ipo
ipos
life
littered
make
medical
nash
new
news
open
price
q
quarter
remains
road
roundup
science
strategy
talk
way
week
window
Language
Current search:
antibiotics
×
merck
×
" indiana blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way